Based on these observations, one can hypothesize that the selective requirement of NOTCH2 signals for the development of normal splenic marginal zone B cells provides a functional basis for the involvement of NOTCH2 mutations in SMZL and not in other B malignancies, such as CLL, that derive from other cell types. This evidence concerns the gene NOTCH2 and B-cell chronic lymphocytic leukemia.